ọgwụgwọ Ezubere iche maka nnyefe ọgwụ maka ụlọ ọgwụ ọrịa kansa

Nnyefe ọgwụ ezubere iche maka ọgwụgwọ maka ụlọ ọgwụ ọrịa kansa

Ntuziaka a zuru oke na-enyocha ọganihu na ngwa nke ọgwụgwọ ezubere iche nnyefe ọgwụ n'ime ọnọdụ nke ụlọ ọgwụ cancer. Anyị na-enyocha ụzọ dị iche iche, uru, ihe ịma aka, na ntụzịaka ọdịnihu nke ubi a dị oke mkpa, na-enye nghọta dị mkpa maka ndị ọkachamara ahụike na ndị nyocha. Ozi ewepụtara na-adabere na akwụkwọ sayensị ugbu a na omume ụlọ ọrụ.

Ịghọta nnyefe ọgwụ ezubere iche

Kedu ihe bụ nnyefe ọgwụ ezubere iche?

Ọgwụgwọ ezubere iche maka nnyefe ọgwụ Emebere sistemu iji nyefee ndị na-ahụ maka ọgwụgwọ na sel ndị nwere ọrịa kansa ma na-ebelata mmebi nke anụ ahụ dị mma. Ụzọ a na-achọ ịkwalite nrụpụta ọrụ, belata mmetụta ndị na-adịghị mma, ma melite nsonaazụ ndị ọrịa n'ozuzu ya ma e jiri ya tụnyere usoro ọgwụgwọ chemotherapy omenala. Enwere ọtụtụ atụmatụ iji nweta nnyefe a ezubere iche, gụnyere conjugates ọgwụ mgbochi mmadụ, nanoparticles, na liposomes.

Usoro nke Omume

Sistemụ ndị a na-ejikarị ligands lekwasịrị anya, dị ka ọgwụ mgbochi ọrịa ma ọ bụ peptides, nke na-ejikọ kpọmkwem na ndị na-anabata ya nke ukwuu na mkpụrụ ndụ kansa. Ozugbo ejikọtara ya, a na-ahapụ ọgwụ ahụ, na-eduga na ọgwụgwọ mpaghara na mbelata nsí sistemu. Nhọrọ nke usoro nnyefe na-adabere n'ihe ndị dị ka ụdị ọrịa cancer, ihe onwunwe ọgwụ, na mmetụta ọgwụgwọ achọrọ. The arụmọrụ nke ọgwụgwọ ezubere iche maka nnyefe ọgwụ maka ụlọ ọgwụ kansa na-emewanyewanye nke ọma site na nyocha na-aga n'ihu.

Ụzọ esi ebufe ọgwụ ezubere iche

Njikọ Antibody-Drug Conjugates (ADCs)

ADCs na-ejikọta ọgwụ cytotoxic na mgbochi monoclonal nke na-elekwasị anya kpọmkwem antigen cancer. Usoro a na-eme ka a mara na a na-ebunye ọgwụ ahụ n'ụzọ bụ isi na mkpụrụ ndụ kansa, na-egbochi ikpughe usoro na ibelata mmetụta ọjọọ. Ọtụtụ ADC ka akwadoro maka ojiji ụlọ ọgwụ ma na-arụkwa ọrụ oge niile na usoro ọgwụgwọ ọrịa kansa. Ọmụmaatụ gụnyere trastuzumab emtansine (Kadcyla) na brentuximab vedotin (Adcetris).

Nnyefe dabere na mkpụrụ akụ

Nanoparticles, dị ka liposomes, polymeric nanoparticles, na inorganic nanoparticles, nwere ike encapsulate ọgwụgwọ ọgwụ na welie ha nnyefe na etuto ahụ. Enwere ike imezi ihe ndị a ka ha wee lekwasị anya na sel na anụ ahụ, na-eme ka mkpokọta ọgwụ dị n'ime microenvironment tumor. Shandong Baofa Cancer Research Institute https://www.baofahospital.com/ bụ onye mbụ n'ime nyocha a.

Nnyefe ọgwụ Liposomal

Liposomes bụ vesicles gburugburu nke nwere phospholipid bilayers nke nwere ike itinye ọgwụ ọgwụgwọ dị iche iche. Ha na-enye nchebe pụọ na mmebi ma nwee ike ịkwalite oge mgbasa ozi ọgwụ. Ọzọkwa, enwere ike gbanwee liposomes iji lekwasị sel ma ọ bụ anụ ahụ anya kpọmkwem, na-eme ka nnyefe ọgwụ na-aga n'ihu na saịtị tumor. Docetaxel, ọgwụ chemotherapy nke a na-ejikarị eme ihe, na-emepụtakarị n'ụdị liposomal iji meziwanye nrụpụta ya ma belata mmetụta ya.

Uru na ihe ịma aka nke nnyefe ọgwụ ezubere iche

Ntuziaka ọdịnihu na nnyefe ọgwụ ezubere iche maka ọrịa kansa

Nchọpụta na-aga n'ihu na-elekwasị anya n'ịzụlite ọkaibe karịa ọgwụgwọ ezubere iche nnyefe ọgwụ Sistemu nwere nkọwapụta nlebara anya emelitere, mbelata nsị, yana nkwalite ọgwụgwọ arụ ọrụ. Nke a gụnyere inyocha ligands ezubere iche akwụkwọ akụkọ, iji usoro onyonyo dị elu maka nyochaa nnyefe ọgwụ, yana imepụta ụzọ ahaziri iche dabere na njirimara onye ọrịa n'otu n'otu. Njikọ nke nanotechnology na immunotherapy na-enye nkwa dị ịrịba ama maka ọganihu ndị ọzọ n'ọhịa.

Mmepe na mmejuputa nke ọma ọgwụgwọ ezubere iche maka nnyefe ọgwụ maka ụlọ ọgwụ kansa chọrọ mmekorita mmekọrịta dị n'etiti ndị nyocha, ndị dọkịta na ụlọ ọrụ ọgwụ. Ntinye ego na-aga n'ihu na nyocha na mmepe dị oke mkpa maka ịtụgharị ọganihu ndị a ka ọ bụrụ nlekọta ndị ọrịa ka mma na nsonaazụ ya.

¹ Data na ozi sitere na akwụkwọ akụkọ sayensị dị iche iche ama ama na webụsaịtị ụlọ ọrụ ọgwụ. Ntụnyere aka dị ka achọrọ.